Xencor Inc Cash Flow Statement
XNCR / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
Xencor Inc used $135M in operating cash flow and negative free cash flow of $138M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.27 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$91.9M | -$232.6M | -$133.1M | -$55.2M | $26.9M | -$69.3M | -$38.5M | $45.1M | -$38.5M | $45.1M | -$17.6M | -$16.4M | -$60.3M |
| Depreciation & Amortization | $10.5M | $12.1M | $11.5M | $8.8M | $4.3M | $5.8M | $2.0M | $1.5M | $2.0M | $1.5M | $1.1M | $882.0K | $711.0K |
| Operating Cash Flow | -$135.1M | -$202.2M | -$77.9M | $24.5M | $64.4M | -$5.0M | -$33.6M | $95.2M | -$33.6M | $95.2M | $26.7M | -$21.4M | -$5.5M |
| Capital Expenditures | $3.1M | $6.1M | $18.4M | $38.5M | $7.4M | $10.5M | $5.3M | $1.5M | $5.3M | $1.5M | $1.9M | $780.0K | $136.0K |
| Free Cash Flow | -$138.3M | -$208.3M | -$96.4M | -$14.0M | $57.0M | -$15.5M | -$38.9M | $93.7M | -$38.9M | $93.7M | $24.7M | -$22.1M | -$5.6M |
| FCF Margin | -110.1% | -188.5% | -55.2% | -8.5% | 36.4% | -12.7% | -84.3% | 86.0% | - | - | - | - | - |